Skip to content

Biohaven BHVN Other Non-Current Assets

Other Non-Current Assets at other companies

Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$1.06M+401%
uniQure logo
uniQureQURE
$5.54M+2.1%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$832K+89.1%
Eli Lilly logo
Eli LillyLLY
Roivant Sciences logo
Roivant SciencesROIV
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's other non-current assets?
Biohaven (BHVN) reported other non-current assets of $45.71M in Q1 2026.
How has Biohaven's other non-current assets changed year-over-year?
Biohaven's other non-current assets increased by 18.4% year-over-year, from $38.61M to $45.71M.
What is the long-term trend for Biohaven's other non-current assets?
Over 4 years (2021 to 2025), Biohaven's other non-current assets has grown at a 34.6% compound annual growth rate (CAGR), from $14.44M to $47.36M.
What does other non-current assets mean?
This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.